Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Neoplasms of the CNS

  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 225 articles:
HTML format

Single Articles

    January 2024
  1. AZIMI P, Karimpour M, Yazdanian T, Totonchi M, et al
    Comprehensive somatic mutational analysis in glioblastoma: Implications for precision medicine approaches.
    PLoS One. 2024;19:e0295698.
    PubMed     Abstract available

  2. ZOTEVA V, De Meulenaere V, De Boeck M, Vanhove C, et al
    An improved F98 glioblastoma rat model to evaluate novel treatment strategies incorporating the standard of care.
    PLoS One. 2024;19:e0296360.
    PubMed     Abstract available

  3. BURTON B, Collins K, Brooks J, Marx K, et al
    Correction: The biotoxin BMAA promotes dysfunction via distinct mechanisms in neuroblastoma and glioblastoma cells.
    PLoS One. 2024;19:e0296579.
    PubMed     Abstract available

  4. LI R, Chen Y, Yang B, Li Z, et al
    Integrated bioinformatics analysis and experimental validation identified CDCA families as prognostic biomarkers and sensitive indicators for rapamycin treatment of glioma.
    PLoS One. 2024;19:e0295346.
    PubMed     Abstract available

  5. WU X, Yang X, Li Z, Liu L, et al
    Multimodal brain tumor image segmentation based on DenseNet.
    PLoS One. 2024;19:e0286125.
    PubMed     Abstract available

  6. BROOKS AM, Vornoli A, Kovi RC, Ton TVT, et al
    Genetic profiling of rat gliomas and cardiac schwannomas from life-time radiofrequency radiation exposure study using a targeted next-generation sequencing gene panel.
    PLoS One. 2024;19:e0296699.
    PubMed     Abstract available

  7. JUST U, Burtscher H, Jeratsch S, Fischer M, et al
    Proteomic and transcriptomic characterisation of FIA10, a novel murine leukemic cell line that metastasizes into the brain.
    PLoS One. 2024;19:e0295641.
    PubMed     Abstract available

  8. Retraction: MicroRNA-330 Is an Oncogenic Factor in Glioblastoma Cells by Regulating SH3GL2 Gene.
    PLoS One. 2024;19:e0297950.

  9. WOHLSEIN JC, Meurer M, Morgelin M, Nessler JN, et al
    Neutrophil extracellular traps in CSF and serum of dogs with steroid-responsive meningitis-arteritis.
    PLoS One. 2024;19:e0295268.
    PubMed     Abstract available

  10. DE VILLIERS O, Elliot-Wilson C, Thomas KGF, Semple PL, et al
    Sleep and cognition in South African patients with non-functioning pituitary adenomas.
    PLoS One. 2024;19:e0296387.
    PubMed     Abstract available

  11. ZECHEL C, Loy M, Wegner C, Dahlke E, et al
    Molecular signature of stem-like glioma cells (SLGCs) from human glioblastoma and gliosarcoma.
    PLoS One. 2024;19:e0291368.
    PubMed     Abstract available

  12. FIVEASH JB, Ye X, Peerboom DM, Mikkelsen T, et al
    Clinical trials of R-(-)-gossypol (AT-101) in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702.
    PLoS One. 2024;19:e0291128.
    PubMed     Abstract available

  13. PAN C, Bai X, Li N, Zheng N, et al
    PBX3 as a biomarker for the early diagnosis and prediction of prognosis of glioma.
    PLoS One. 2024;19:e0293647.
    PubMed     Abstract available

  14. CHOHAN MO, Flores RA, Wertz C, Jung RE, et al
    "Non-Eloquent" brain regions predict neuropsychological outcome in tumor patients undergoing awake craniotomy.
    PLoS One. 2024;19:e0284261.
    PubMed     Abstract available

  15. STRUBLOVA L, Kepak T, Kuruczova D, Zlamal F, et al
    Socioeconomic status and adiposity in childhood cancer survivors: A cross-sectional retrospective study.
    PLoS One. 2024;19:e0298068.
    PubMed     Abstract available

  16. HASSAN H, Mirza MR, Jabeen A, Alam M, et al
    Yellow scorpion (Buthus sinidicus) venom peptides induce mitochondrial-mediated apoptosis in cervical, prostate and brain tumor cell lines.
    PLoS One. 2024;19:e0296636.
    PubMed     Abstract available

  17. ZOTEVA V, De Meulenaere V, Vanhove C, Leybaert L, et al
    Integrating and optimizing tonabersat in standard glioblastoma therapy: A preclinical study.
    PLoS One. 2024;19:e0300552.
    PubMed     Abstract available

  18. SALAS-GALLARDO GA, Lorea-Hernandez JJ, Robles-Gomez AA, Del Campo CC, et al
    Morphological differentiation of peritumoral brain zone microglia.
    PLoS One. 2024;19:e0297576.
    PubMed     Abstract available

  19. SUN MA, Yao H, Yang Q, Pirozzi CJ, et al
    Gene expression analysis suggests immunosuppressive roles of endolysosomes in glioblastoma.
    PLoS One. 2024;19:e0299820.
    PubMed     Abstract available

  20. JIN X, Zhu J, Yu H, Shi S, et al
    Dysregulation of LINC00324 promotes poor prognosis in patients with glioma.
    PLoS One. 2024;19:e0298055.
    PubMed     Abstract available

  21. SUN B, Lu W, Yu W, Tian Y, et al
    Prevalence and risk factors of early postoperative seizures in patients with glioma: A protocol for meta-analysis and systematic review.
    PLoS One. 2024;19:e0301443.
    PubMed     Abstract available

  22. WANG L, Wang H, D'Angelo F, Curtin L, et al
    Quantifying intra-tumoral genetic heterogeneity of glioblastoma toward precision medicine using MRI and a data-inclusive machine learning algorithm.
    PLoS One. 2024;19:e0299267.
    PubMed     Abstract available

  23. JAMBOR I, Steiner A, Pesola M, Gardberg M, et al
    Relaxation Along a Fictitious Field, continuous wave T1rho, adiabatic T1rho and adiabatic T2rho imaging of human gliomas at 3T: A feasibility study.
    PLoS One. 2024;19:e0296958.
    PubMed     Abstract available

  24. QI Z, Yu H, Chen L, Qu Y, et al
    Analysis and prediction of central nervous system tumor burden in China during 1990-2030.
    PLoS One. 2024;19:e0300390.
    PubMed     Abstract available

  25. AUNG TM, Ngamjarus C, Proungvitaya T, Saengboonmee C, et al
    Biomarkers for prognosis of meningioma patients: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0303337.
    PubMed     Abstract available

  26. XUE H, Lu H, Wang Y, Li N, et al
    MCE: Medical Cognition Embedded in 3D MRI feature extraction for advancing glioma staging.
    PLoS One. 2024;19:e0304419.
    PubMed     Abstract available

  27. CUI C, Yang T, Wang S, Jia Z, et al
    Discussion on the relationship between gut microbiota and glioma through Mendelian randomization test based on the brain gut axis.
    PLoS One. 2024;19:e0304403.
    PubMed     Abstract available

  28. Retraction: Rescue of MHC-1 Antigen Processing Machinery by Down-Regulation in Expression of IGF-1 in Human Glioblastoma Cells.
    PLoS One. 2024;19:e0305595.

  29. STEFANOVIC M, Jovanovic I, Zivkovic M, Stankovic A, et al
    Pathway analysis of peripheral blood CD8+ T cell transcriptome shows differential regulation of sphingolipid signaling in multiple sclerosis and glioblastoma.
    PLoS One. 2024;19:e0305042.
    PubMed     Abstract available

  30. WANG Y, Zhong F, Xiao F, Li J, et al
    Host-defence caerin 1.1 and 1.9 peptides suppress glioblastoma U87 and U118 cell proliferation through the modulation of mitochondrial respiration and induce the downregulation of CHI3L1.
    PLoS One. 2024;19:e0304149.
    PubMed     Abstract available

  31. HAN Y, Wang Y, Li S, Sato K, et al
    Exploration of the shared pathways and common biomarker in adamantinomatous craniopharyngioma and type 2 diabetes using integrated bioinformatics analysis.
    PLoS One. 2024;19:e0304404.
    PubMed     Abstract available

  32. VEIGA VC, Peres SV, Ostolin TLVDP, Moraes FR, et al
    Incidence of venous thromboembolism and bleeding in patients with malignant central nervous system neoplasm: Systematic review and meta-analysis.
    PLoS One. 2024;19:e0304682.
    PubMed     Abstract available

  33. ZHENG K, Murphy MC, Camerucci E, Plitt AR, et al
    Improved quantification of tumor adhesion in meningiomas using MR elastography-based slip interface imaging.
    PLoS One. 2024;19:e0305247.
    PubMed     Abstract available

  34. RAYMOND D, Fukui M, Zwernik S, Kassam A, et al
    Evaluating soluble Axl as a biomarker for glioblastoma: A pilot study.
    PLoS One. 2024;19:e0301739.
    PubMed     Abstract available

  35. HONG S, Wu J, Zhu L, Chen W, et al
    Brain tumor classification in VIT-B/16 based on relative position encoding and residual MLP.
    PLoS One. 2024;19:e0298102.
    PubMed     Abstract available

  36. ARNLJOTS U, Nilsson M, Bolzani R, Benassi M, et al
    Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.
    PLoS One. 2024;19:e0305548.
    PubMed     Abstract available

  37. PARK H, Kim JH, Lee CH, Kim S, et al
    The utility of intraoperative ultrasonography for spinal cord surgery.
    PLoS One. 2024;19:e0305694.
    PubMed     Abstract available

    January 2023
  38. ZHANG L, Qu C, Shi C, Wu F, et al
    Association of RNA-modification "writer" genes with prognosis and response to immunotherapy in patients with low-grade glioma.
    PLoS One. 2023;18:e0279119.
    PubMed     Abstract available

  39. JARUTHIEN T, Nantavithya C, Santisukwongchote S, Shuangshoti S, et al
    Postoperative radiotherapy timing, molecular subgroups and treatment outcomes of Thai pediatric patients with medulloblastoma.
    PLoS One. 2023;18:e0271778.
    PubMed     Abstract available

  40. PRUMMER JK, Stein VM, Marti E, Lutterotti A, et al
    Assessment of oligoclonal bands in cerebrospinal fluid and serum of dogs with meningoencephalitis of unknown origin.
    PLoS One. 2023;18:e0280864.
    PubMed     Abstract available

  41. EBINA K, Matsui M, Kinoshita M, Saito D, et al
    The effect of damage to the white matter network and premorbid intellectual ability on postoperative verbal short-term memory and functional outcome in patients with brain lesions.
    PLoS One. 2023;18:e0280580.
    PubMed     Abstract available

  42. BLAKSTAD H, Brekke J, Rahman MA, Arnesen VS, et al
    Survival in a consecutive series of 467 glioblastoma patients: Association with prognostic factors and treatment at recurrence at two independent institutions.
    PLoS One. 2023;18:e0281166.
    PubMed     Abstract available

  43. DOUGHERTY J, Harvey K, Liou A, Labella K, et al
    Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.
    PLoS One. 2023;18:e0277305.
    PubMed     Abstract available

  44. STEIDL E, Filipski K, Hattingen E, Steinbach JP, et al
    Longitudinal study on MRI and neuropathological findings: Neither DSC-perfusion derived rCBVmax nor vessel densities correlate between newly diagnosed and progressive glioblastoma.
    PLoS One. 2023;18:e0274400.
    PubMed     Abstract available

  45. ZHENG Z, Hu Y, Ren Y, Mo G, et al
    Correlation between metastatic patterns and age in patients with metastatic primary liver cancer: A population-based study.
    PLoS One. 2023;18:e0267809.
    PubMed     Abstract available

  46. WANIGASEKARA J, Carroll LJ, Cullen PJ, Tiwari B, et al
    Three-Dimensional (3D) in vitro cell culture protocols to enhance glioblastoma research.
    PLoS One. 2023;18:e0276248.
    PubMed     Abstract available

  47. SALANS M, Houri J, Karunamuni R, Hopper A, et al
    The relationship between radiation dose and bevacizumab-related imaging abnormality in patients with brain tumors: A voxel-wise normal tissue complication probability (NTCP) analysis.
    PLoS One. 2023;18:e0279812.
    PubMed     Abstract available

  48. THEAKSTONE AG, Brennan PM, Jenkinson MD, Goodacre R, et al
    Investigating centrifugal filtration of serum-based FTIR spectroscopy for the stratification of brain tumours.
    PLoS One. 2023;18:e0279669.
    PubMed     Abstract available

  49. JAHEDI A, Kumar G, Kannan L, Agarwal T, et al
    Gibbs process distinguishes survival and reveals contact-inhibition genes in Glioblastoma multiforme.
    PLoS One. 2023;18:e0277176.
    PubMed     Abstract available

  50. BJORKNES B, Neye OE, Hamerlik P, Jauffred L, et al
    Immunostaining protocol for infiltrating brain cancer spheroids for light-sheet imaging.
    PLoS One. 2023;18:e0281161.
    PubMed     Abstract available

  51. HAQ MFU, Hussain MZ, Mahjabeen I, Akram Z, et al
    Oncometabolic role of mitochondrial sirtuins in glioma patients.
    PLoS One. 2023;18:e0281840.
    PubMed     Abstract available

  52. BURTON B, Collins K, Brooks J, Marx K, et al
    The biotoxin BMAA promotes dysfunction via distinct mechanisms in neuroblastoma and glioblastoma cells.
    PLoS One. 2023;18:e0278793.
    PubMed     Abstract available

  53. SANG H, Cho YK, Han K, Koh EH, et al
    Impact of abdominal obesity on the risk of glioma development in patients with diabetes: A nationwide population-based cohort study in Korea.
    PLoS One. 2023;18:e0283023.
    PubMed     Abstract available

  54. SUGITA Y, Takada S, Tanigaki K, Muraki K, et al
    Inhibition of VEGF receptors induces pituitary apoplexy: An experimental study in mice.
    PLoS One. 2023;18:e0279634.
    PubMed     Abstract available

  55. SAILUNAZ K, Bestepe D, Alhajj S, Ozyer T, et al
    Brain tumor detection and segmentation: Interactive framework with a visual interface and feedback facility for dynamically improved accuracy and trust.
    PLoS One. 2023;18:e0284418.
    PubMed     Abstract available

  56. DE GROOT JD, van Dijken BRJ, van der Weide HL, Enting RH, et al
    Voxel based morphometry-detected white matter volume loss after multi-modality treatment in high grade glioma patients.
    PLoS One. 2023;18:e0275077.
    PubMed     Abstract available

  57. TUCKER DW, Pangal DJ, Du R, Gogia AS, et al
    Validation of Myc-Associated Protein X (MAX) regulation in growth hormone secreting and nonfunctional pituitary adenoma.
    PLoS One. 2023;18:e0284949.
    PubMed     Abstract available

  58. JUNG M, Jeong Y, Park BJ
    Adaptation of families of adult patients with brain tumor: Partial least squares structural equation modeling.
    PLoS One. 2023;18:e0285677.
    PubMed     Abstract available

  59. DENES A, Bontell TO, Barcheus H, Vega SF, et al
    The clinical value of proneural, classical and mesenchymal protein signatures in WHO 2021 adult-type diffuse lower-grade gliomas.
    PLoS One. 2023;18:e0285732.
    PubMed     Abstract available

  60. KIMURA K, Chun JH, Lin YL, Liang YC, et al
    Tetra-O-methyl-nordihydroguaiaretic acid inhibits energy metabolism and synergistically induces anticancer effects with temozolomide on LN229 glioblastoma tumors implanted in mice while preventing obesity in normal mice that consume high-fat diets.
    PLoS One. 2023;18:e0285536.
    PubMed     Abstract available

  61. DADHANIA S, Pakzad-Shahabi L, Mistry S, Williams M, et al
    Triaxial accelerometer-measured physical activity and functional behaviours among people with High Grade Glioma: The BrainWear Study.
    PLoS One. 2023;18:e0285399.
    PubMed     Abstract available

  62. HUANG Z, Li X, Wei B, Yu Y, et al
    Global metabolomics study on the pathogenesis of pediatric medulloblastoma via UPLC- Q/E-MS/MS.
    PLoS One. 2023;18:e0287121.
    PubMed     Abstract available

  63. HALLUNDBAEK L, Hagstrom S, Mathiasen R, Herlin T, et al
    Musculoskeletal misdiagnoses in children with brain tumors: A nationwide, multicenter case-control study.
    PLoS One. 2023;18:e0279549.
    PubMed     Abstract available

  64. NYHOLM L, Zetterling M, Elf K
    Sleep in neurointensive care patients, and patients after brain tumor surgery.
    PLoS One. 2023;18:e0286389.
    PubMed     Abstract available

  65. MISCHKULNIG M, Hopp B, Wadiura LI, Khalaveh F, et al
    Treatment of high-grade glioma patients during the COVID-19 pandemic: Impact on overall survival, tumor size and delay of treatment.
    PLoS One. 2023;18:e0287993.
    PubMed     Abstract available

  66. KUROKAWA R, Kurokawa M, Baba A, Kim J, et al
    Dynamic susceptibility contrast perfusion-weighted and diffusion-weighted magnetic resonance imaging findings in pilocytic astrocytoma and H3.3 and H3.1 variant diffuse midline glioma, H3K27-altered.
    PLoS One. 2023;18:e0288412.
    PubMed     Abstract available

  67. SHEN L, Zhang Y, Wang Q, Qin F, et al
    Feature interaction network based on hierarchical decoupled convolution for 3D medical image segmentation.
    PLoS One. 2023;18:e0288658.
    PubMed     Abstract available

  68. LEE H, Lee JW, Cho HW, Choe YS, et al
    Methionine metabolism and endocrine function of the pituitary gland in patients with suprasellar germinoma.
    PLoS One. 2023;18:e0288528.
    PubMed     Abstract available

  69. MOLYNEAUX K, Laggner C, Vincent J, Brady-Kalnay S, et al
    Small molecule antagonists of PTPmu identified by artificial intelligence-based computational screening block glioma cell migration and growth.
    PLoS One. 2023;18:e0288980.
    PubMed     Abstract available

  70. XIONG J, Wang M, Gao J, Zhou Y, et al
    Propofol suppresses hormones levels more obviously than sevoflurane in pediatric patients with craniopharyngioma: A prospective randomized controlled clinical trial.
    PLoS One. 2023;18:e0288863.
    PubMed     Abstract available

  71. WANG Y, Wu Y, Li L, Gao J, et al
    GDNF triggers proliferation of rat C6 glioma cells via the NF-kappaB/CXCL1 signaling pathway.
    PLoS One. 2023;18:e0289071.
    PubMed     Abstract available

  72. VERGARA GA, Eugenio GC, Fleury Malheiros SM, Victor EDS, et al
    Higher Mixed lineage Kinase Domain-like protein (MLKL) is associated with worst overall survival in adult-type diffuse glioma patients.
    PLoS One. 2023;18:e0291019.
    PubMed     Abstract available

  73. YU H, Liu M, Zhang X, Ma T, et al
    The effect of tranexamic acid on intraoperative blood loss in patients undergoing brain meningioma resections: Study protocol for a randomized controlled trial.
    PLoS One. 2023;18:e0290725.
    PubMed     Abstract available

  74. NDUOM EK, Glod J, Brown DA, Fagan M, et al
    Clinical protocol: Feasibility of evaluating abemaciclib neuropharmacokinetics of diffuse midline glioma using intratumoral microdialysis.
    PLoS One. 2023;18:e0291068.
    PubMed     Abstract available

  75. WANG C, Li P
    Risk factors for intraoperative blood loss in resection of intracranial meningioma: Analysis of 530 cases.
    PLoS One. 2023;18:e0291171.
    PubMed     Abstract available

  76. Retraction: Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma.
    PLoS One. 2023;18:e0291490.

  77. LI W, Lv D, Yao J, Chen B, et al
    A pan-cancer analysis reveals the diagnostic and prognostic role of CDCA2 in low-grade glioma.
    PLoS One. 2023;18:e0291024.
    PubMed     Abstract available

  78. CHOATE KA, Raack EJ, Line VF, Jennings MJ, et al
    Rapid extraction-free detection of the R132H isocitrate dehydrogenase mutation in glioma using colorimetric peptide nucleic acid-loop mediated isothermal amplification (CPNA-LAMP).
    PLoS One. 2023;18:e0291666.
    PubMed     Abstract available

  79. ULLAH N, Javed A, Alhazmi A, Hasnain SM, et al
    TumorDetNet: A unified deep learning model for brain tumor detection and classification.
    PLoS One. 2023;18:e0291200.
    PubMed     Abstract available

  80. GLOBUS O, Sagie S, Lavine N, Barchana DI, et al
    Early death after a diagnosis of metastatic solid cancer-raising awareness and identifying risk factors from the SEER database.
    PLoS One. 2023;18:e0281561.
    PubMed     Abstract available

  81. LE MK, Vuong HG, Dunn IF, Kondo T, et al
    Molecular and clinicopathological implications of PRAME expression in adult glioma.
    PLoS One. 2023;18:e0290542.
    PubMed     Abstract available

  82. SAKOWITZ S, Bakhtiyar SS, Mallick S, Khoraminejad B, et al
    Decreasing rates of colectomy for benign neoplasms: A nationwide analysis.
    PLoS One. 2023;18:e0293389.
    PubMed     Abstract available

  83. SUHAIL M, Tarique M, Tabrez S, Zughaibi TA, et al
    Synergistic inhibition of glioblastoma multiforme through an in-silico analysis of luteolin and ferulic acid derived from Angelica sinensis and Cannabis sativa: Advancements in computational therapeutics.
    PLoS One. 2023;18:e0293666.
    PubMed     Abstract available

  84. BONERT M, Berzins A, Begum H, Schittenhelm J, et al
    Neuroanatomical location of brain metastases from solid tumours based on pathology: An analysis of 511 patients with a comparison to the provided clinical history.
    PLoS One. 2023;18:e0294154.
    PubMed     Abstract available

  85. GAO X, Zhang F, Zhou Q, Xu H, et al
    Metastasis, characteristic, and treatment of breast cancer in young women and older women: A study from the Surveillance, Epidemiology, and End Results registration database.
    PLoS One. 2023;18:e0293830.
    PubMed     Abstract available

  86. ANTTONEN J, Remes T, Arikoski P, Lahteenmaki P, et al
    Correction: Pre- and postdiagnosis growth failure, adult short stature, and untreated growth hormone deficiency in radiotherapy-treated long-term survivors of childhood brain tumor.
    PLoS One. 2023;18:e0294792.
    PubMed     Abstract available

  87. NASSANI R, Bokhari Y, Alrfaei BM
    Molecular signature to predict quality of life and survival with glioblastoma using Multiview omics model.
    PLoS One. 2023;18:e0287448.
    PubMed     Abstract available

  88. VERISSIMO DCA, Camillo-Andrade AC, Santos MDM, Sprengel SL, et al
    Proteomics reveals differentially regulated pathways when comparing grade 2 and 4 astrocytomas.
    PLoS One. 2023;18:e0290087.
    PubMed     Abstract available

  89. YOON HG, Cheong JH, Ryu JI, Won YD, et al
    The genes significantly associated with an improved prognosis and long-term survival of glioblastoma.
    PLoS One. 2023;18:e0295061.
    PubMed     Abstract available

  90. MAKRANZ C, Lubotzky A, Zemmour H, Shemer R, et al
    Short report: Plasma based biomarkers detect radiation induced brain injury in cancer patients treated for brain metastasis: A pilot study.
    PLoS One. 2023;18:e0285646.
    PubMed     Abstract available

  91. KAHOLONGO NO, Mashingaidze-Mano R
    Paediatric cancer burden in Namibia: A 10-year retrospective, analytical cohort study of patients admitted at Windhoek Central Hospital.
    PLoS One. 2023;18:e0292794.
    PubMed     Abstract available

  92. FAN ST, Xu HQ, He Y, Tu MX, et al
    Overexpression of TMEM150A in glioblastoma multiforme patients correlated with dismal prognoses and compromised immune statuses.
    PLoS One. 2023;18:e0294144.
    PubMed     Abstract available

  93. URCUYO JC, Curtin L, Langworthy JM, De Leon G, et al
    Image-localized biopsy mapping of brain tumor heterogeneity: A single-center study protocol.
    PLoS One. 2023;18:e0287767.
    PubMed     Abstract available

  94. HONG CS, Smith TR
    Aerobic exercise interventions to address impaired quality of life in patients with pituitary tumors.
    PLoS One. 2023;18:e0295907.
    PubMed     Abstract available

    January 2022
  95. WU C, Zhong J, Lin L, Chen Y, et al
    Segmentation of HE-stained meningioma pathological images based on pseudo-labels.
    PLoS One. 2022;17:e0263006.
    PubMed     Abstract available

  96. JAVIER R, Wang W, Drumm M, McCortney K, et al
    The efficacy of an unrestricted cycling ketogenic diet in preclinical models of IDH wild-type and IDH mutant glioma.
    PLoS One. 2022;17:e0257725.
    PubMed     Abstract available

  97. VILLATORO AJ, Alcoholado C, Martin-Astorga MDC, Rubio N, et al
    Suicide gene therapy by canine mesenchymal stem cell transduced with thymidine kinase in a u-87 glioblastoma murine model: Secretory profile and antitumor activity.
    PLoS One. 2022;17:e0264001.
    PubMed     Abstract available

  98. POWER EA, Fernandez-Torres J, Zhang L, Yaun R, et al
    Chorioallantoic membrane (CAM) assay to study treatment effects in diffuse intrinsic pontine glioma.
    PLoS One. 2022;17:e0263822.
    PubMed     Abstract available

  99. VAN DIJKEN BRJ, Ankrah AO, Stormezand GN, Dierckx RAJO, et al
    Prognostic value of 11C-methionine volume-based PET parameters in IDH wild type glioblastoma.
    PLoS One. 2022;17:e0264387.
    PubMed     Abstract available

  100. ZHANG H, Zhu S, Xing Y, Liu Q, et al
    Effect of cryopreservation on A172 and U251 glioma cells infected with lentiviral vectors designed for CRISPR/Cas9-mediated aquaporin-8 knock-out.
    PLoS One. 2022;17:e0263162.
    PubMed     Abstract available

  101. FITT B, Loy G, Christopher E, Brennan PM, et al
    Analytic approaches to clinical validation of results from preclinical models of glioblastoma: A systematic review.
    PLoS One. 2022;17:e0264740.
    PubMed     Abstract available

  102. VERYASKINA YA, Titov SE, Ivanov MK, Ruzankin PS, et al
    Selection of reference genes for quantitative analysis of microRNA expression in three different types of cancer.
    PLoS One. 2022;17:e0254304.
    PubMed     Abstract available

  103. PARK YJ, Lee JW, Cho HW, Choe YS, et al
    Value of C-11 methionine PET/CT in patients with intracranial germinoma.
    PLoS One. 2022;17:e0263690.
    PubMed     Abstract available

  104. BEAUMONT J, Gambarota G, Prior M, Fripp J, et al
    Avoiding data loss: Synthetic MRIs generated from diffusion imaging can replace corrupted structural acquisitions for freesurfer-seeded tractography.
    PLoS One. 2022;17:e0247343.
    PubMed     Abstract available

  105. WILLIAMS G, Llewelyn A, Thatcher R, Hardisty KM, et al
    Utilisation of semiconductor sequencing for the detection of predictive biomarkers in glioblastoma.
    PLoS One. 2022;17:e0245817.
    PubMed     Abstract available

  106. COLLI SL, Cardoso N, Massone CA, Cores M, et al
    Molecular alterations in the integrated diagnosis of pediatric glial and glioneuronal tumors: A single center experience.
    PLoS One. 2022;17:e0266466.
    PubMed     Abstract available

  107. SEKI Y, Ichihara A
    Association between overweight and growth hormone secretion in patients with non-functioning pituitary tumors.
    PLoS One. 2022;17:e0267324.
    PubMed     Abstract available

  108. KANG YM, Lee YY, Lin SC, Chang FC, et al
    Bifocal lesions have a poorer treatment outcome than a single lesion in adult patients with intracranial germinoma.
    PLoS One. 2022;17:e0264641.
    PubMed     Abstract available

  109. Retraction: Secreted Frizzled-Related Protein 4 Inhibits Glioma Stem-Like Cells by Reversing Epithelial to Mesenchymal Transition, Inducing Apoptosis and Decreasing Cancer Stem Cell Properties.
    PLoS One. 2022;17:e0268372.

  110. Retraction: Enhanced Anti-Tumor Effect of Zoledronic Acid Combined with Temozolomide against Human Malignant Glioma Cell Expressing O6-Methylguanine DNA Methyltransferase.
    PLoS One. 2022;17:e0268315.

  111. KARRI R, Chen YP, Drummond KJ
    Using machine learning to predict health-related quality of life outcomes in patients with low grade glioma, meningioma, and acoustic neuroma.
    PLoS One. 2022;17:e0267931.
    PubMed     Abstract available

  112. LUGTU EJ, Ramos DB, Agpalza AJ, Cabral EA, et al
    Artificial neural network in the discrimination of lung cancer based on infrared spectroscopy.
    PLoS One. 2022;17:e0268329.
    PubMed     Abstract available

  113. Retraction: BRMS1 Suppresses Glioma Progression by Regulating Invasion, Migration and Adhesion of Glioma Cells.
    PLoS One. 2022;17:e0270174.

  114. MAO DD, Cleary RT, Gujar A, Mahlokozera T, et al
    CDC20 regulates sensitivity to chemotherapy and radiation in glioblastoma stem cells.
    PLoS One. 2022;17:e0270251.
    PubMed     Abstract available

  115. REN J, Da J, Hu N
    Identification of COL1A1 associated with immune infiltration in brain lower grade glioma.
    PLoS One. 2022;17:e0269533.
    PubMed     Abstract available

  116. TUNTHANATHIP T, Sae-Heng S, Oearsakul T, Kaewborisutsakul A, et al
    Economic impact of a machine learning-based strategy for preparation of blood products in brain tumor surgery.
    PLoS One. 2022;17:e0270916.
    PubMed     Abstract available

  117. THAKUR JD, Mallari RJ, Corlin A, Yawitz S, et al
    Critical appraisal of minimally invasive keyhole surgery for intracranial meningioma in a large case series.
    PLoS One. 2022;17:e0264053.
    PubMed     Abstract available

  118. RIGTER LS, Snaebjornsson P, Rosenberg EH, Altena E, et al
    Molecular characterization of gastric adenocarcinoma diagnosed in patients previously treated for Hodgkin lymphoma or testicular cancer.
    PLoS One. 2022;17:e0270591.
    PubMed     Abstract available

  119. VASSILIEVA A, Moller K, Skjoth-Rasmussen J, Sorensen MK, et al
    Hyperlactatemia associated with elective tumor craniotomy: Protocol for an observational study of pathophysiology and clinical implications.
    PLoS One. 2022;17:e0271682.
    PubMed     Abstract available

  120. PAUL DA, Rodrigue A, Contento N, Haber S, et al
    Prolactin at moderately increased levels confers a neuroprotective effect in non-secreting pituitary macroadenomas.
    PLoS One. 2022;17:e0271690.
    PubMed     Abstract available

  121. ELMTALAB S, Abedi I, Alirezaei Z, Choopan Dastjerdi MH, et al
    Semi-experimental assessment of neutron equivalent dose and secondary cancer risk for off-field organs in glioma patients undergoing 18-MV radiotherapy.
    PLoS One. 2022;17:e0271028.
    PubMed     Abstract available

  122. BUCHLAK QD, Esmaili N, Bennett C, Wang YY, et al
    Predictors of improvement in quality of life at 12-month follow-up in patients undergoing anterior endoscopic skull base surgery.
    PLoS One. 2022;17:e0272147.
    PubMed     Abstract available

  123. GULDAGER R, Loft MI, Nordentoft S, Aadal L, et al
    Facilitators and barriers of relatives' involvement in nursing care decisions and self-care of patients with acquired brain injury or malignant brain tumour: A scoping review protocol.
    PLoS One. 2022;17:e0273151.
    PubMed     Abstract available

  124. LASICA N, Djilvesi D, Papic V, Karan M, et al
    Venous thromboembolic and hemorrhagic events after meningioma surgery: A single-center retrospective cohort study of risk factors.
    PLoS One. 2022;17:e0273189.
    PubMed     Abstract available

  125. HATTORI Y, Kurozumi K, Otani Y, Uneda A, et al
    Combination of Ad-SGE-REIC and bevacizumab modulates glioma progression by suppressing tumor invasion and angiogenesis.
    PLoS One. 2022;17:e0273242.
    PubMed     Abstract available

  126. ACQUARELLI J, van Laarhoven T, Postma GJ, Jansen JJ, et al
    Convolutional neural networks to predict brain tumor grades and Alzheimer's disease with MR spectroscopic imaging data.
    PLoS One. 2022;17:e0268881.
    PubMed     Abstract available

  127. PECULIS R, Rovite V, Megnis K, Balcere I, et al
    Whole exome sequencing reveals novel risk genes of pituitary neuroendocrine tumors.
    PLoS One. 2022;17:e0265306.
    PubMed     Abstract available

  128. KUZNICKI ML, Mallen A, Ha K, McClung EC, et al
    Prognostic features of endometrial cancer metastasis to the central nervous system.
    PLoS One. 2022;17:e0268794.
    PubMed     Abstract available

  129. ANTTONEN J, Remes T, Arikoski P, Lahteenmaki P, et al
    Pre- and postdiagnosis growth failure, adult short stature, and untreated growth hormone deficiency in radiotherapy-treated long-term survivors of childhood brain tumor.
    PLoS One. 2022;17:e0274274.
    PubMed     Abstract available

  130. REIGSTAD A, Herdlevaer CF, Rigg E, Hoang T, et al
    CCT196969 effectively inhibits growth and survival of melanoma brain metastasis cells.
    PLoS One. 2022;17:e0273711.
    PubMed     Abstract available

  131. GUNES S, He Z, Tsoukou E, Ng SW, et al
    Cell death induced in glioblastoma cells by Plasma-Activated-Liquids (PAL) is primarily mediated by membrane lipid peroxidation and not ROS influx.
    PLoS One. 2022;17:e0274524.
    PubMed     Abstract available

  132. SHIM YB, Byun JY, Lee JY, Lee EK, et al
    Economic burden of brain metastases in non-small cell lung cancer patients in South Korea: A retrospective cohort study using nationwide claims data.
    PLoS One. 2022;17:e0274876.
    PubMed     Abstract available

  133. SCHADEWALDT V, Cherkil S, Panikar D, Drummond KJ, et al
    Quality of life after resection of a meningioma-A cross-cultural comparison of Indian and Australian patients.
    PLoS One. 2022;17:e0275184.
    PubMed     Abstract available

  134. SHEN L, Li Y, Li N, Shen L, et al
    Comprehensive analyses reveal the role of histone deacetylase genes in prognosis and immune response in low-grade glioma.
    PLoS One. 2022;17:e0276120.
    PubMed     Abstract available

  135. ROQUES M, Catalaa I, Raveneau M, Attal J, et al
    Assessment of the hypervascularized fraction of glioblastomas using a volume analysis of dynamic susceptibility contrast-enhanced MRI may help to identify pseudoprogression.
    PLoS One. 2022;17:e0270216.
    PubMed     Abstract available

  136. TAN SC, Low TY, Hussain HMJ, Sharzehan MAK, et al
    Association between XRCC3 p.Thr241Met polymorphism and risk of glioma: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0276313.
    PubMed     Abstract available

  137. WON SY, Lee JH, Lee N, Park YW, et al
    Three-dimensional fractal dimension and lacunarity features may noninvasively predict TERT promoter mutation status in grade 2 meningiomas.
    PLoS One. 2022;17:e0276342.
    PubMed     Abstract available

  138. DUSSEL V, Orellana L, Holder R, Porth R, et al
    A multisite randomized controlled trial of an early palliative care intervention in children with advanced cancer: The PediQUEST Response Study Protocol.
    PLoS One. 2022;17:e0277212.
    PubMed     Abstract available

  139. SUNDBLOM J, Skare TP, Holm O, Welin S, et al
    Central nervous system hemangioblastomas in von Hippel-Lindau disease: Total growth rate and risk of developing new lesions not associated with circulating VEGF levels.
    PLoS One. 2022;17:e0278166.
    PubMed     Abstract available

  140. FERNANDEZ-GALLARDO M, Corzo-Lopez A, Munoz-Herrera D, Leyva-Leyva M, et al
    Role of the Ca2+ channel alpha2delta-1 auxiliary subunit in proliferation and migration of human glioblastoma cells.
    PLoS One. 2022;17:e0279186.
    PubMed     Abstract available

  141. GERRITSEN JKW, Rizopoulos D, Schouten JW, Haitsma IK, et al
    Impact of dedicated neuro-anesthesia management on clinical outcomes in glioblastoma patients: A single-institution cohort study.
    PLoS One. 2022;17:e0278864.
    PubMed     Abstract available

    January 2021
  142. WHITE ML, Zhang Y, Kazmi SAJ, Aizenberg M, et al
    Evaluating survival in subjects with astrocytic brain tumors by dynamic susceptibility-weighted perfusion MR imaging.
    PLoS One. 2021;16:e0244275.
    PubMed     Abstract available

  143. SHI H, Song Y, Song Z, Huang C, et al
    CKMT1B is a potential prognostic biomarker and associated with immune infiltration in Lower-grade glioma.
    PLoS One. 2021;16:e0245524.
    PubMed     Abstract available

  144. ZHAO Y, Zhang X, Yao J
    Comprehensive analysis of PLOD family members in low-grade gliomas using bioinformatics methods.
    PLoS One. 2021;16:e0246097.
    PubMed     Abstract available

  145. LIM J, Park Y, Ahn JW, Hwang SJ, et al
    Maximal surgical resection and adjuvant surgical technique to prolong the survival of adult patients with thalamic glioblastoma.
    PLoS One. 2021;16:e0244325.
    PubMed     Abstract available

  146. YU VY, Nguyen D, O'Connor D, Ruan D, et al
    Treating Glioblastoma Multiforme (GBM) with super hyperfractionated radiation therapy: Implication of temporal dose fractionation optimization including cancer stem cell dynamics.
    PLoS One. 2021;16:e0245676.
    PubMed     Abstract available

  147. ALI S, Borin TF, Piranlioglu R, Ara R, et al
    Changes in the tumor microenvironment and outcome for TME-targeting therapy in glioblastoma: A pilot study.
    PLoS One. 2021;16:e0246646.
    PubMed     Abstract available

  148. JUNG HW, Kim HY, Kim JY, Cheon JE, et al
    Cardiac autonomic dysfunction is associated with hypothalamic damage in patients with childhood-onset craniopharyngioma.
    PLoS One. 2021;16:e0246789.
    PubMed     Abstract available

  149. CAVATORTA C, Meroni S, Montin E, Oprandi MC, et al
    Retrospective study of late radiation-induced damages after focal radiotherapy for childhood brain tumors.
    PLoS One. 2021;16:e0247748.
    PubMed     Abstract available

  150. JIANG Z, Shi Y, Tan G, Wang Z, et al
    Computational screening of potential glioma-related genes and drugs based on analysis of GEO dataset and text mining.
    PLoS One. 2021;16:e0247612.
    PubMed     Abstract available

  151. BOLCAEN J, Descamps B, Deblaere K, De Vos F, et al
    Assessment of the effect of therapy in a rat model of glioblastoma using [18F]FDG and [18F]FCho PET compared to contrast-enhanced MRI.
    PLoS One. 2021;16:e0248193.
    PubMed     Abstract available

  152. LAMMER F, Delbridge C, Wurstle S, Neff F, et al
    Correction: Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma.
    PLoS One. 2021;16:e0248612.
    PubMed     Abstract available

  153. LIM J, Park Y, Ahn JW, Sim J, et al
    Autologous adoptive immune-cell therapy elicited a durable response with enhanced immune reaction signatures in patients with recurrent glioblastoma: An open label, phase I/IIa trial.
    PLoS One. 2021;16:e0247293.
    PubMed     Abstract available

  154. YE ZP, He HY, Wang H, Li WS, et al
    Retraction: Glioma-Derived ADAM10 Induces Regulatory B Cells to Suppress CD8+ T Cells.
    PLoS One. 2021;16:e0249104.

  155. CAO Y, Yang R, Lee I, Zhang W, et al
    Prediction of LncRNA-encoded small peptides in glioma and oligomer channel functional analysis using in silico approaches.
    PLoS One. 2021;16:e0248634.
    PubMed     Abstract available

  156. Correction: Assessment of Amide proton transfer weighted (APTw) MRI for pre-surgical prediction of final diagnosis in gliomas.
    PLoS One. 2021;16:e0250189.
    PubMed     Abstract available

  157. PROST DM, Merenzon MA, Gomez-Escalante JI, Primavera A, et al
    Effects of time to chemoradiation on high-grade gliomas from the Buenos Aires Metropolitan Area.
    PLoS One. 2021;16:e0249486.
    PubMed     Abstract available

  158. GIHR G, Horvath-Rizea D, Hekeler E, Ganslandt O, et al
    Diffusion weighted imaging in high-grade gliomas: A histogram-based analysis of apparent diffusion coefficient profile.
    PLoS One. 2021;16:e0249878.
    PubMed     Abstract available

  159. NONAKA M, Mabashi-Asazuma H, Jarvis DL, Yamasaki K, et al
    Development of an orally-administrable tumor vasculature-targeting therapeutic using annexin A1-binding D-peptides.
    PLoS One. 2021;16:e0241157.
    PubMed     Abstract available

  160. WANG L, Liu Y, Xuan C, Liu Y, et al
    Identification of ubiquitination-related genes in human glioma as indicators of patient prognosis.
    PLoS One. 2021;16:e0250239.
    PubMed     Abstract available

  161. WILLIFORD SE, Libby CJ, Ayokanmbi A, Otamias A, et al
    Novel dopamine receptor 3 antagonists inhibit the growth of primary and temozolomide resistant glioblastoma cells.
    PLoS One. 2021;16:e0250649.
    PubMed     Abstract available

  162. Correction: Three-dimensional visualization of brain tumor progression based accurate segmentation via comparative holographic projection.
    PLoS One. 2021;16:e0251614.
    PubMed     Abstract available

  163. SHIN C, Kim JM, Cheong JH, Ryu JI, et al
    Association between tumor size and peritumoral brain edema in patients with convexity and parasagittal meningiomas.
    PLoS One. 2021;16:e0252945.
    PubMed     Abstract available

  164. DORRELL MI, Kast-Woelbern HR, Botts RT, Bravo SA, et al
    A novel method of screening combinations of angiostatics identifies bevacizumab and temsirolimus as synergistic inhibitors of glioma-induced angiogenesis.
    PLoS One. 2021;16:e0252233.
    PubMed     Abstract available

  165. GARRETT C, Becker TM, Lynch D, Po J, et al
    Comparison of neutrophil to lymphocyte ratio and prognostic nutritional index with other clinical and molecular biomarkers for prediction of glioblastoma multiforme outcome.
    PLoS One. 2021;16:e0252614.
    PubMed     Abstract available

  166. ROY S, Maji P
    Multispectral co-occurrence of wavelet coefficients for malignancy assessment of brain tumors.
    PLoS One. 2021;16:e0250964.
    PubMed     Abstract available

  167. LIU H, Chen C, Zeng J, Zhao Z, et al
    MicroRNA-210-3p is transcriptionally upregulated by hypoxia induction and thus promoting EMT and chemoresistance in glioma cells.
    PLoS One. 2021;16:e0253522.
    PubMed     Abstract available

  168. FUCHS J, Fruh M, Papachristofilou A, Bubendorf L, et al
    Resection of isolated brain metastases in non-small cell lung cancer (NSCLC) patients - evaluation of outcome and prognostic factors: A retrospective multicenter study.
    PLoS One. 2021;16:e0253601.
    PubMed     Abstract available

  169. LEE S, Choi SH, Cho HR, Koh J, et al
    Multiparametric magnetic resonance imaging features of a canine glioblastoma model.
    PLoS One. 2021;16:e0254448.
    PubMed     Abstract available

  170. JOHANN P, Lenz D, Ries M
    The drug development pipeline for glioblastoma-A cross sectional assessment of the FDA Orphan Drug Product designation database.
    PLoS One. 2021;16:e0252924.
    PubMed     Abstract available

  171. HEYDASCH U, Kessler R, Warnke JP, Eschrich K, et al
    Functional diversity of PFKFB3 splice variants in glioblastomas.
    PLoS One. 2021;16:e0241092.
    PubMed     Abstract available

  172. CHANG LS, Oblinger JL, Smith AE, Ferrer M, et al
    Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK.
    PLoS One. 2021;16:e0252048.
    PubMed     Abstract available

  173. ALENDA C, Rojas E, Valor LM
    FFPE samples from cavitational ultrasonic surgical aspirates are suitable for RNA profiling of gliomas.
    PLoS One. 2021;16:e0255168.
    PubMed     Abstract available

  174. CHANG FC, Wong TT, Wu KS, Lu CF, et al
    Magnetic resonance radiomics features and prognosticators in different molecular subtypes of pediatric Medulloblastoma.
    PLoS One. 2021;16:e0255500.
    PubMed     Abstract available

  175. MALLARI RJ, Avery MB, Corlin A, Eisenberg A, et al
    Streamlining brain tumor surgery care during the COVID-19 pandemic: A case-control study.
    PLoS One. 2021;16:e0254958.
    PubMed     Abstract available

  176. HUANG YH, Wu ZF, Lee MS, Lou YS, et al
    Propofol-based total intravenous anesthesia is associated with better survival than desflurane anesthesia in glioblastoma surgery.
    PLoS One. 2021;16:e0255627.
    PubMed     Abstract available

  177. BANAN R, Akbarian A, Samii M, Samii A, et al
    Diffuse midline gliomas, H3 K27M-mutant are associated with less peritumoral edema and contrast enhancement in comparison to glioblastomas, H3 K27M-wildtype of midline structures.
    PLoS One. 2021;16:e0249647.
    PubMed     Abstract available

  178. LUO EW, Liao ML, Chien CL
    Neural differentiation of glioblastoma cell lines via a herpes simplex virus thymidine kinase/ganciclovir system driven by a glial fibrillary acidic protein promoter.
    PLoS One. 2021;16:e0253008.
    PubMed     Abstract available

  179. MOHAMMADI E, Ghasemi E, Azadnajafabad S, Rezaei N, et al
    A global, regional, and national survey on burden and Quality of Care Index (QCI) of brain and other central nervous system cancers; global burden of disease systematic analysis 1990-2017.
    PLoS One. 2021;16:e0247120.
    PubMed     Abstract available

  180. KUO CY, Lee CC, Lee YL, Liou SC, et al
    Visual light perceptions caused by medical linear accelerator: Findings of machine-learning algorithms in a prospective questionnaire-based case-control study.
    PLoS One. 2021;16:e0247597.
    PubMed     Abstract available

  181. KWON HJ, Oh YT, Park S, Kim SS, et al
    Analysis of electric cigarette liquid effect on mouse brain tumor growth through EGFR and ERK activation.
    PLoS One. 2021;16:e0256730.
    PubMed     Abstract available

  182. JAIN S, Mazaheri B, Raviv N, Bruck J, et al
    Glioblastoma signature in the DNA of blood-derived cells.
    PLoS One. 2021;16:e0256831.
    PubMed     Abstract available

  183. LEE SH, Kwon HJ, Park S, Kim CI, et al
    Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP downregulates stemness phenotype and mesenchymal trans-differentiation after irradiation in glioblastoma multiforme.
    PLoS One. 2021;16:e0257375.
    PubMed     Abstract available

  184. BOWLES EJA, Miglioretti DL, Kwan ML, Bartels U, et al
    Long-term medical imaging use in children with central nervous system tumors.
    PLoS One. 2021;16:e0248643.
    PubMed     Abstract available

  185. NAYAK C, Singh SK
    In silico identification of natural product inhibitors against Octamer-binding transcription factor 4 (Oct4) to impede the mechanism of glioma stem cells.
    PLoS One. 2021;16:e0255803.
    PubMed     Abstract available

  186. MINH DUC N
    The diagnostic function of intravoxel incoherent motion for distinguishing between pilocytic astrocytoma and ependymoma.
    PLoS One. 2021;16:e0247899.
    PubMed     Abstract available

  187. STANIC D, Grujicic D, Pekmezovic T, Bokun J, et al
    Clinical profile, treatment and outcome of pediatric brain tumors in Serbia in a 10-year period: A national referral institution experience.
    PLoS One. 2021;16:e0259095.
    PubMed     Abstract available

  188. BENNEBROEK CAM, Wijninga LE, Limpens J, Schouten-van Meeteren AYN, et al
    Impact of systemic anticancer therapy in pediatric optic pathway glioma on visual function: A systematic review.
    PLoS One. 2021;16:e0258548.
    PubMed     Abstract available

  189. SEOMUN G, Lee J, Park J
    Exposure to extremely low-frequency magnetic fields and childhood cancer: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0251628.
    PubMed     Abstract available

  190. MELO SM, Marta GN, Latorraca COC, Martins CB, et al
    Hypofractionated radiotherapy for newly diagnosed elderly glioblastoma patients: A systematic review and network meta-analysis.
    PLoS One. 2021;16:e0257384.
    PubMed     Abstract available

  191. SERRA R, Zhao T, Huq S, Gorelick NL, et al
    Disulfiram and copper combination therapy targets NPL4, cancer stem cells and extends survival in a medulloblastoma model.
    PLoS One. 2021;16:e0251957.
    PubMed     Abstract available

  192. TAKASHIMA Y, Kawaguchi A, Fukai J, Iwadate Y, et al
    Survival prediction based on the gene expression associated with cancer morphology and microenvironment in primary central nervous system lymphoma.
    PLoS One. 2021;16:e0251272.
    PubMed     Abstract available

  193. ZHANG Q, Yun KK, Wang H, Yoon SW, et al
    Automatic cell counting from stimulated Raman imaging using deep learning.
    PLoS One. 2021;16:e0254586.
    PubMed     Abstract available

  194. RANA R, Rathi V, Chauhan K, Jain K, et al
    Exploring the role of epidermal growth factor receptor variant III in meningeal tumors.
    PLoS One. 2021;16:e0255133.
    PubMed     Abstract available

  195. VERES G, Vas NF, Lyngby Lassen M, Beresova M, et al
    Effect of grey-level discretization on texture feature on different weighted MRI images of diverse disease groups.
    PLoS One. 2021;16:e0253419.
    PubMed     Abstract available

  196. YAN JL, Chang CN, Chen PY
    Endoscopic transsphenoidal surgery for resection of pituitary macroadenoma: A retrospective study.
    PLoS One. 2021;16:e0255599.
    PubMed     Abstract available

  197. WU Q, Yin X, Zhao W, Xu W, et al
    Downregulation of SFRP2 facilitates cancer stemness and radioresistance of glioma cells via activating Wnt/beta-catenin signaling.
    PLoS One. 2021;16:e0260864.
    PubMed     Abstract available

  198. CONIGLIO SJ, Segall JE
    Microglial-stimulation of glioma invasion involves the EGFR ligand amphiregulin.
    PLoS One. 2021;16:e0260252.
    PubMed     Abstract available

  199. LIU Y, Liu Y, Gao Y, Wang L, et al
    H19- and hsa-miR-338-3p-mediated NRP1 expression is an independent predictor of poor prognosis in glioblastoma.
    PLoS One. 2021;16:e0260103.
    PubMed     Abstract available

  200. NUIJTS MA, Imhof SM, Veldhuis N, Dekkers CC, et al
    The diagnostic accuracy and prognostic value of OCT for the evaluation of the visual function in children with a brain tumour: A systematic review.
    PLoS One. 2021;16:e0261631.
    PubMed     Abstract available

  201. CHOI SS, Choi H, Baek IC, Park SA, et al
    HLA polymorphisms and risk of glioblastoma in Koreans.
    PLoS One. 2021;16:e0260618.
    PubMed     Abstract available

  202. AN C, Park YW, Ahn SS, Han K, et al
    Radiomics machine learning study with a small sample size: Single random training-test set split may lead to unreliable results.
    PLoS One. 2021;16:e0256152.
    PubMed     Abstract available

  203. CENNAMO G, Solari D, Montorio D, Scala MR, et al
    The role of OCT- angiography in predicting anatomical and functional recovery after endoscopic endonasal pituitary surgery: A 1-year longitudinal study.
    PLoS One. 2021;16:e0260029.
    PubMed     Abstract available

    January 2020
  204. NUIJTS MA, Veldhuis N, Stegeman I, van Santen HM, et al
    Visual functions in children with craniopharyngioma at diagnosis: A systematic review.
    PLoS One. 2020;15:e0240016.
    PubMed     Abstract available

  205. CRANE AT, Chrostek MR, Krishna VD, Shiao M, et al
    Zika virus-based immunotherapy enhances long-term survival of rodents with brain tumors through upregulation of memory T-cells.
    PLoS One. 2020;15:e0232858.
    PubMed     Abstract available

  206. WENINGER L, Na CH, Jutten K, Merhof D, et al
    Analyzing the effects of free water modeling by deep learning on diffusion MRI structural connectivity estimates in glioma patients.
    PLoS One. 2020;15:e0239475.
    PubMed     Abstract available

  207. CHELEBIAN E, Fuster-Garcia E, Alvarez-Torres MDM, Juan-Albarracin J, et al
    Higher vascularity at infiltrated peripheral edema differentiates proneural glioblastoma subtype.
    PLoS One. 2020;15:e0232500.
    PubMed     Abstract available

  208. ZHANG J, Li YI, Pieters TA, Towner J, et al
    Sepsis and septic shock after craniotomy: Predicting a significant patient safety and quality outcome measure.
    PLoS One. 2020;15:e0235273.
    PubMed     Abstract available

  209. GUERREIRO EM, Ovstebo R, Thiede B, Costea DE, et al
    Cancer cell line-specific protein profiles in extracellular vesicles identified by proteomics.
    PLoS One. 2020;15:e0238591.
    PubMed     Abstract available

  210. TAN TH, Chen D, Soon YY, Chee Seong Tey J, et al
    Quality of reporting of cranial irradiation techniques in randomized controlled trials of primary brain tumors: A systematic review.
    PLoS One. 2020;15:e0241566.
    PubMed     Abstract available

  211. HUANG J, Milchenko M, Rao YJ, LaMontagne P, et al
    A feasibility study to evaluate early treatment response of brain metastases one week after stereotactic radiosurgery using perfusion weighted imaging.
    PLoS One. 2020;15:e0241835.
    PubMed     Abstract available

  212. CHO JH, Lim YC, Han KD, Lee JY, et al
    The incidence of malignant brain tumors is increased in patients with obstructive sleep apnea: A national health insurance survey.
    PLoS One. 2020;15:e0241598.
    PubMed     Abstract available

  213. SAADEH FS, Morsi RZ, El-Kurdi A, Nemer G, et al
    Correlation of genetic alterations by whole-exome sequencing with clinical outcomes of glioblastoma patients from the Lebanese population.
    PLoS One. 2020;15:e0242793.
    PubMed     Abstract available

  214. HARATI R, Hafezi S, Mabondzo A, Tlili A, et al
    Silencing miR-202-3p increases MMP-1 and promotes a brain invasive phenotype in metastatic breast cancer cells.
    PLoS One. 2020;15:e0239292.
    PubMed     Abstract available

  215. ACHIHA T, Kijima N, Kodama Y, Kagawa N, et al
    Activated leukocyte cell adhesion molecule expression correlates with the WNT subgroup in medulloblastoma and is involved in regulating tumor cell proliferation and invasion.
    PLoS One. 2020;15:e0243272.
    PubMed     Abstract available

  216. DE MEULENAERE V, Descamps B, De Wever O, Vanhove C, et al
    In vivo selection of the MDA-MB-231br/eGFP cancer cell line to obtain a clinically relevant rat model for triple negative breast cancer brain metastasis.
    PLoS One. 2020;15:e0243156.
    PubMed     Abstract available

  217. INHESTERN L, Peikert ML, Krauth KA, Escherich G, et al
    Parents' perception of their children's process of reintegration after childhood cancer treatment.
    PLoS One. 2020;15:e0239967.
    PubMed     Abstract available

  218. KRUSEOVA J, Kovacova AS, Zapotocky M, Sumerauer D, et al
    Older age is a protective factor for academic achievements irrespective of treatment modalities for posterior fossa brain tumours in children.
    PLoS One. 2020;15:e0243998.
    PubMed     Abstract available

  219. TOGAO O, Chikui T, Tokumori K, Kami Y, et al
    Gamma distribution model of diffusion MRI for the differentiation of primary central nerve system lymphomas and glioblastomas.
    PLoS One. 2020;15:e0243839.
    PubMed     Abstract available

  220. CENNAMO G, Solari D, Montorio D, Scala MR, et al
    Early vascular modifications after endoscopic endonasal pituitary surgery: The role of OCT-angiography.
    PLoS One. 2020;15:e0241295.
    PubMed     Abstract available

  221. WU B, Jiang S, Wang X, Zhong S, et al
    Identification of driver genes and key pathways of non-functional pituitary adenomas predicts the therapeutic effect of STO-609.
    PLoS One. 2020;15:e0240230.
    PubMed     Abstract available

  222. WANG JL, Barth RF, Cavaliere R, Puduvalli VK, et al
    Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas.
    PLoS One. 2020;15:e0244383.
    PubMed     Abstract available

  223. DURMO F, Rydhog A, Testud F, Latt J, et al
    Assessment of Amide proton transfer weighted (APTw) MRI for pre-surgical prediction of final diagnosis in gliomas.
    PLoS One. 2020;15:e0244003.
    PubMed     Abstract available

  224. YOUNES ST, Herrington B
    In silico analysis identifies a putative cell-of-origin for BRAF fusion-positive cerebellar pilocytic astrocytoma.
    PLoS One. 2020;15:e0242521.
    PubMed     Abstract available

  225. CHEN T, Ren Y, Wang C, Huang B, et al
    Risk factors for hydrocephalus following fourth ventricle tumor surgery: A retrospective analysis of 121 patients.
    PLoS One. 2020;15:e0241853.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.